Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 78 of 78 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/01/21
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 09/16/21
End: 01/02/25
Due: 01/02/26
Phase: N/A
Priority: Normal
Start: 06/15/21
End: 12/30/24
Due: 12/30/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms | NCT05315856 | Korea University Guro Hospital | user2@example.com | None | 2021-03-01 | 2022-12-31 | 2023-12-31 | - | - | 2025-07-14 |
| Deep Neuromuscular Block on Postoperative Delirium in Lumbar Surgery | NCT05453929 | Korea University Guro Hospital | user2@example.com | None | 2021-09-16 | 2025-01-02 | 2026-01-02 | - | - | 2025-07-14 |
| Neratinib and Trastuzumab Biosimilar in Patients with HER2 Mutated Advanced Solid Cancers | NCT06083662 | Korea University Guro Hospital | user2@example.com | None | 2021-06-15 | 2024-12-30 | 2025-12-30 | - | - | 2025-07-14 |